{"member_organisations": "http://www.vaccineseurope.eu/about-vaccines-europe/vaccines-europe-members/ \n \nVaccines Europe's constituent entities include 13 member companies", "identification_number": "53073567234-18", "fields_of_interest": "Economy, finance and the euro, Trade, Competition, Consumers, Education and training, Business and Industry, Single market, Research and innovation, External Relations, Public Health", "head_office_address": "EFPIA ASBL 8, rue Mil Neuf Cents", "full_time_equivalent_fte": "1,75", "person_with_legal_responsibility": "Stefan Oschmann", "industry_forums": "", "grants": "", "inter_groups": "", "eu_initiatives": "Any health or pharmaceutical policy stemming from the European Institutions such as: \n- Anti Microbial Resistance \n- Preparedness and response to public health emergencies \n- HTA \n-IMI \n- Commission initiatives on vaccination", "level_of_interest": "European", "organisation_name": "Vaccines Europe (VE)", "belgium_office_post_code": "1050", "number_of_persons_involved": "4", "person_in_charge_of_eu_relations": "Nathalie Moll", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "subsection": "Trade and business associations", "belgium_office_phone": "(+32)26262567", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "Rue du Tr\u00f4ne 108", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "RODRIGUEZ DE AZERO#Magdalena, VISIC#Andrija", "registration_date": "23/11/2011", "estimate_of_costs_absolute_amount": "360747", "website_address": "http://www.vaccineseurope.eu/", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Luxembourg", "membership": "Vaccines Europe operates as a specialised group within the European Federation of Pharmaceutical Industries and Associations \u2013 EFPIA-, which operates as the representative organisation of the pharmaceutical industry in Europe.", "head_office_post_code": "2157", "position": "EFPIA Director General", "financial_year_start_date": "01/01/2017", "head_office_country": "Luxembourg", "number_of_ep_accredited_persons": "2", "relevant_communication": "Recent publications: \n-Publication in Vaccine- Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "", "overall_budget_turnover_absolute_amount": "0", "legal_status": "a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA)", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "The aim of Vaccines Europe, which has no profit-making purpose is to: \n\u2022Create a supportive environment for improved vaccine protection and coverage in the interest of individuals and the community \n\u2022Promote vaccine R & D to meet new challenges for innovative vaccine applications against infectious and other types of diseases \n\u2022Foster a favourable policy climate for the vaccine industry in Europe to bring new vaccines to the world.", "belgium_office_city": "Brussels", "head_office_phone": "(+352)26845416"}